The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic-;an effective antiviral that has since successfully treated millions.

Researchers at Caltech have developed bioresorbable acoustic microrobots (BAM) capable of delivering therapeutic drugs ...

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID-19 and Ebola—while also minimizing side effects and reducing the odds of ...

Professor Jennifer Van Eyk joined Technology Networks for an exclusive interview at HUPO 2024 to discuss progress and ...

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

What everyone wants to see is a system where one can have confidence in these tests and not have to question whether they’ve ...

Notably, the House NIH reform proposal seeks to shrink the agency, not add institutes. The proposal, which Rep. Robert ...

With November coming to a close, while markets are focused on the future of artificial intelligence and the degree of ...

In the 520-page report, the House Select Subcommittee on the Coronavirus Pandemic concludes that the coronavirus "most likely ...

The Supreme Court on Monday pressed the Food and Drug Administration on whether it followed the law in its effort to keep ...

Bringing a drug to market from drug discovery to U.S. FDA approval can take upwards of 15 years at a cost of $2.5 billion.